The comparison of six-month and four-month regimens of chemotherapy in the treatment of smear positive pulmonary tuberculosis

Journal of Medical Sciences

Volumn 6, Issue 1, 2006, Pages 108-111

  Sharifi Mood, Batool ^a   Metanat, Malihe ^a   Alavi Naini, Roya ^a   Kouhpayeh, Hamid Reza ^a   Salehi, Masoud ^a   Naderi, Mohammad ^a   Hashemi Shahri, S Mohammad ^a   Naser Poor, Taghi ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemotherapy; Failure rate; Relapse rate; Tuberculosis; Zahedan

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HUMAN; IRAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; RELAPSE; SPUTUM SMEAR; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33644617188     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2006.108.111     Document Type: Article

References (26)

1. David, W.H., 2000. Mycobacterium Tuberculosis. In: Principles and Practice of Infectious Diseases. 5th Edn., (Eds.) G.1. mandell, J.e. bennette, D. Raphael. Philadelphia: Chrchill Livingstone, pp: 2580-2592.
2. Anonymous, 2003. Treatment of Tuberculosis. Am. Thoracic. Soc. CDC Infect. Dis. Soc. MMWR., 52: 1-17.
3. Michael, D.I., 2000. Tuberculosis Chemotherapy. In: A Clinicians, Guide to Tb., pp: 211-220.
4. Fridman, L.N., 2001. TB Current Concept and Treatment. 2nd Edn., pp: 208-211
5. Narayanan, P.R., 2002. A randomised clinical trial for treatment of smear positive pulmonary tuberculosis with regimens using ofloxacin in the intensive phase. Ind. J. Tub., 49: 27-38.
6. Moghtaderi, A. and R. Alavi-Naini., 2003. Tuberculous radiculomyelitis; Review and presentation of 5 cases. Intl. J. Tub. Lung Dis., 7: 1186-1190.
7. Sharifi-Mood, B., M. Metanat and M.R. Metanat, 1996. A comparative study on relapse rate and failure rate in 6 and 9/months regimens in pulmonary tuberculosis in Zabol. Intl Bull Zahedan Health Center, Iran, pp: 31-39.
8. Anonymous, 1989. A controled treatment of 3-4-6 month regimens of chemotherapy for sputum smear negative and culture negative pulmonary TB result 5 years. Hong-Kong chest service tuberculosis Madras-britain research center. Am. Rev. Res. Dis., 134: 871-877.
9. Anonymous, 1986. A controlled clinical trial of 3 and 5 month regimens in the treatment of sputum -smear positive pulmonary tuberculosis in South India. Tuberculosis Research Center, Madras. National Tuberculosis Institue. Am. Rev. Res. Dis., 134: 27.
10. Eule, H., H. Beck and H. Evers, 1982. Daily and intermittent short -course chemotherapy using 4 drugs in recently detected bacillary pulmonary tuberculosis. Bull. Intl. Union Tub., 57: 63.
11. Anonymous, 1982. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuiberculosis. East African/British medical Research Council Study. Am. Rev. Res. Dis., 123: 165.
12. Anonymous, 1981. Clinical Trial of six month and four month regimens of chemothrapy in the treatment of pulmonary tuberculosis. The result up to 24 months. Singapore Tuberculosis Service/British Medical Research Council, Tubercle, 62: 95.
13. Anonymous, 1994. Treatment of tuberculosis infection in adult and children. Am. J. Res. Crit. Care Med., 149: 1359-1374.
14. Davidson, V. and Le-Ho, 1992. Drug treatment of TB Drugs, 43: 651-657
15. Anonymous, 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Res. Crit. Care Med., 161: 221.
16. Anonymous, 2003. Treatment of tuberculosis. Centers for Diseases Control and Prevention. Am. J. Res. Crit. Care Med., 167: 603
17. Burman, W.G. and B.E. Jones, 2002. Treatment of HIV associated tuberculosis in the era of effective antiretroviral therapy. Am. J. Res. Crit. Care Med., 164: 7.
18. Anonymous, 2003. Treatment of Tuberculosis, A guidelines for national programmes. Geneva. WHO, pp: 321-327.
19. Young, D.B., 2003. Ten years of research progress and what,s to come. Tuberculosis, 83: 77
20. Anonymous, 2003. Treatment of tuberculosis. MMWR., 52: 1-77
21. Chadha, S.L. and R.P. Bhagi, 2001. Treatment outcome in tuberculosis patients under directly observed treatment Short course (DOTs) a short study. Ind. J. Tub., 47: 155-8
22. Santha, T., O. Nazareth and M.S. Krishnamurty, 1989. Treatment of pulmonary tuberculosis patients treated with short course chemotherapy regimen in South India 5 year follow-up. Tub. J., 70: 229-234
23. Dutt, A.K., D.Mores., W.W. Stead, 1984. Short course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampicin 7-years experiences with mainly outpatients. Am. J. Med., 77: 232-242
24. Davidson, P.T. and H.Q. Le, 1992. Drug treatment of tuberculosis. Drugs, 43: 651-673
25. Cohn, D.L., B.L. Catlin and K.I. peterson, 1990. A 62-dose, 6/months the rapy for pulmonary and extrapulmonary tuberculosis; A twice weekly directly observed and cost effective regimen. Am. Intl. Med., 112: 407 415
26. Perez Stable, E.J. and P.C. Hopewell, 1989. Current tuberculosis treatment regimens; Choosing the right one for young patients. Clin. Chest Med., 10: 323-339